Health

Startups and SMEs gain access to:

1. Strategic Distribution Partners: Vetted distributors across global markets who understand longevity innovations and follow high ethical standards;
2. Educational Resources: Market intelligence, regulatory guidance, expansion strategies, and business leadership best practices;
3. Investor Connections: Introductions to investors specifically interested in longevity and healthtech, and focused on companies seeking market expansion;
4. Market Expansion Roadmap: Customized strategy for entering target markets;
5. Commercial validation from experienced distributors;
6. Continuous intelligence discussions about the latest discussions of key events, congresses and innovation hubs.

Innovators willing to share and participate in discussions are welcome to join us. For pre-seed and seed, we offer a sponsored, reduced annual fee, as they tend to benefit more from the learning than from the commercial partnerships. Series A+ startups and established companies are regular participants that can benefit from curated commercial partnerships, investment and fundraising opportunities.

We support two main areas:

• CONSUMER HEALTH (non-prescription): OTC supplements/medicines, consumer wearables, wellness apps, dermacosmetics, DTC lab tests, longevity nutrition, sleep & circadian health, gut health & microbiome products.
• PRESCRIPTION & MEDICAL DEVICES: Diagnostics & Biomarkers, Cardiovascular & Metabolic Health, Neurology & Cognitive Health, Musculoskeletal & Orthopedics, Cellular/Regenerative/Aesthetic Medicine, Digital Health & Remote Monitoring, Women's & Hormonal Health, Hospital Acute Care, Imaging & Respiratory Care, Dental & Oral Health.

While our technology scouting will be primarly focused on longevity innovation, traditional healthcare solutions can also be found as we understand that some of the participants will also benefit from broader portfolio that includes such sorts of products and services.

We will adapt the portfolio being offered as per the idenfied market trends and the discussions with the participants of the group.

Membership fees and early birds special conditions will be announced soon during the week of December 15, 2025.

Yes, pre-seed and seed-stage startups will have special conditions, as KOMPASSIUM will sponsor their participation. For the first year of enrollment in 2026, the final investment per startup will be significantly reduced. Stay tuned on the announcements during the week of December 15, 2025. Contact us at contact@kompassium.com for more information.

This depends on the agreement you negotiate with specific distribution partners. Kaptän has the first rights of refusal every time a new technology is offered in their categories. However, it does not block the innovator to negotiate territorial exclusivity (or not) with the potential commercial partner. This is subject to mutual agreement and typically comes with stronger commitments and support.

Yes, pre-seed and seed-stage startups will have special conditions, as KOMPASSIUM will sponsor their participation. Conditions will be announced during the week of December 15th, 2025.

Contact us at contact@kompassium.com for more information.

We support two main areas:
CONSUMER HEALTH (non-prescription): OTC supplements/medicines, consumer wearables, wellness apps, dermacosmetics, DTC lab tests, longevity nutrition, sleep & circadian health, gut health & microbiome products.

PRESCRIPTION & MEDICAL DEVICES: Diagnostics & Biomarkers, Cardiovascular & Metabolic Health, Neurology & Cognitive Health, Musculoskeletal & Orthopedics, Cellular/Regenerative/Aesthetic Medicine, Digital Health & Remote Monitoring, Women's & Hormonal Health, Hospital Acute Care, Imaging & Respiratory Care, Dental & Oral Health.

While our technology scouting will primarily focus on longevity innovation, we will also identify traditional healthcare solutions based on identified market trends and discussions with group participants, as we understand that some participants will benefit from a broader portfolio that includes such products and services.

We will adapt the portfolio being offered as per the identified market trends and the discussions with the participants of the group.

This depends on the agreement you negotiate with specific distribution partners. KAPTÄN has the first rights of refusal every time a new technology is offered in their categories. However, it does not block the innovator to negotiate territorial exclusivity (or not) with the potential commercial partner. This is subject to mutual agreement and typically comes with stronger commitments and support.

Yes. If the technology is not under review by a KAPTÄN first rights of refusal period, the innovators are open to negotiate with the potential partners that best fit to their strategy.

Our network will provide high quality sourcing opportunity for investors, as well as good fundraising opportunities to startups, without charging additional retainer fees. For when an investment partnership is set, KOMPASSIUM will be commissioned through a very reduced success fee when comparing to market standard practices.

KOMPASSIUM offers comprehensive and additional consulting services, including:

1. Fundraising support and investor introductions;
2. Strategic partnership developments;
3. Innovation pathways and regulatory strategy;
4. Branding and commercial excellence programs;
5. Legacy planning and succession support for family businesses;
6. Market entry strategies and expansion planning;
7. Operational excellence programs;
8. High-quality leadership capability and mentorship, as well as talent management and planning;
9. All required areas for a bold financial planning and execution to support business growth.

KOMPASS is for established distributors who want access to longevity innovations and strategic partnerships. Having access to our platform they can openly search and identify companies they want to discuss a potential partnership agreement. KOMPASS can also benefit by enrolling its team members in the different discussion events that can help them build stronger operations in areas such as:

1. Consumer Insights;
2. Market and Competitive Intelligence;
3. Leadership Upskilling;
4. Team Management;
5. Marketing and Sales efficiency;
6. Branding and Positioning;
7. Post-Sales and Service Operations;
8. Finance and Governance Improvement.

KAPTÄN is for market-leading distributors who want to own the same benefits of KOMPASS members, but also have the first rights to evaluate new technologies before others. KAPTÄN members receive:

1. Additional exclusive meetings;
2. Introduction to investors;
3. Category First Rights of Refusal;
4. Competitive advantage through early access;
5. Invitation to THE MERIDIAN exclusive retail event.

For KAPTÄN members, this means you have the first opportunity to evaluate new innovations in your category before they're offered to other distributors in your territory during 2 months. You can test, approve, and potentially refuse technologies, giving you strategic control and competitive advantage in your market. Once a technology is rejected or the first rights of refusal passes, the solution will be made available in the platform for all other participants.